Afuco™ Anti-Human RTN4R ADCC Therapeutic Antibody, ADCC Enhanced
Anti-RTN4R ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies which bind to the Nogo-66 receptor have utility in the treatment of several states including but not limited to mammalian brain trauma, spinal cord injury, stroke, neurodegenerative diseases, and schizophrenia.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-520CL |
Pricing | Inquiry |
Host | Human |
Target | RTN4R |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | 4°C or -20°C, avoid repeated freezing and thawing. |